Source: GlobeNewswire

Press Release: BDSI : BioDelivery Sciences Announces Upcoming Investor Conference Presentations

RALEIGH, N.C., May 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions today announced that Herm Cukier, Chief Executive Officer will present at the following investor conferences:

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from BDSI's latest SEC filings

Annual Revenue

Based on data from BDSI's latest SEC filings

Employees

Herm Cukier's photo - CEO of BDSI

CEO

Herm Cukier

CEO Approval Rating

84/100

BioDelivery is a pharmaceutical company that primarily focuses on developing medicines for pain management and addiction... Read more